Sugi Predict

Sugi Predict / Targets / CLPTM1

CLPTM1

Putative lipid scramblase CLPTM1 · O96005 · CLPTM1 on Sugi Atlas →

0 patent compounds predicted against CLPTM1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CLPTM1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
The Effects of GLA on Human Volunteers PHASE1COMPLETED
PCD New Gene Discovery nanCOMPLETED
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease nanCOMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Efferocytosis and Genomic Polymorphism in Autoimmune Diseases nanUNKNOWN
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome nanRECRUITING
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Novel Genetic Disorders of the Immune System nanRECRUITING
Epidemiology of Atherosclerosis nanCOMPLETED
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis nanCOMPLETED
Determining the Fingerprint of Endotoxin Tolerance nanCOMPLETED
Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1 nanUNKNOWN
Study of Autoimmune Lymphoproliferative Syndrome (ALPS) nanRECRUITING
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
Proteomic Analysis of Serum Samples After Cardiac Arrest: a TTM-trial Substudy nanACTIVE_NOT_RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Immune Cell Response to Stimuli nanRECRUITING
Pathogenic Mechanisms in C Diff Infection and Colitis nanCOMPLETED
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients nanNOT_YET_RECRUITING
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a CLPTM1 binder may also engage these)

ProteinNameSimilarity
Q2NL17 — 1.000 Q2NL17 →
Q8VBZ3 — 1.000 Q8VBZ3 →
Q6DEL2 — 1.000 Q6DEL2 →
C5GN10 — 0.985 C5GN10 →
Q7SH49 — 0.984 Q7SH49 →
C0NLX2 — 0.984 C0NLX2 →
C0RZV6 — 0.983 C0RZV6 →
C4JDF8 — 0.983 C4JDF8 →
C5JCV0 — 0.983 C5JCV0 →
B0XUW3 — 0.983 B0XUW3 →
C5FZ62 — 0.983 C5FZ62 →
C5PEI5 — 0.982 C5PEI5 →
B6HJA3 — 0.982 B6HJA3 →
D1ZIW5 — 0.982 D1ZIW5 →
A1C7T5 — 0.982 A1C7T5 →
B8N6H2 — 0.981 B8N6H2 →
Q9SYP1 — 0.981 Q9SYP1 →
Q3UDR8 — 0.981 Q3UDR8 →
Q9JIS8 — 0.981 Q9JIS8 →
C1G565 — 0.981 C1G565 →
A2R616 — 0.981 A2R616 →
Q6P9Z1 — 0.981 Q6P9Z1 →
C6H4B5 — 0.980 C6H4B5 →
B4HMY3 — 0.980 B4HMY3 →
B2B2N5 — 0.980 B2B2N5 →
J9VF17 — 0.980 J9VF17 →
A0A078H868 — 0.980 A0A078H868 →
Q4INW6 — 0.980 Q4INW6 →
P0C7N6 — 0.980 P0C7N6 →
Q2H0U8 — 0.979 Q2H0U8 →